As of 2026-04-09, the EV/EBITDA ratio of Aquarius Surgical Technologies Inc (ASTI.CN) is -23.75. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ASTI.CN's latest enterprise value is 6.84 mil CAD. ASTI.CN's TTM EBITDA according to its financial statements is -0.29 mil CAD. Dividing these 2 quantities gives us the above ASTI.CN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 2.1x - 2.7x | 2.5x |
| Forward P/E multiples | 1.7x - 3.3x | 2.5x |
| Fair Price | (0.39) - (0.40) | (0.40) |
| Upside | -2702.3% - -2760.7% | -2739.9% |
| Date | EV/EBITDA |
| 2026-03-27 | -23.75 |
| 2026-03-16 | -23.75 |
| 2026-03-10 | -23.75 |
| 2026-02-26 | -23.44 |
| 2026-02-20 | -23.44 |
| 2026-02-03 | -23.44 |
| 2026-01-30 | -23.44 |
| 2026-01-26 | -23.75 |
| 2026-01-22 | -23.44 |
| 2026-01-12 | -23.75 |
| 2026-01-07 | -23.75 |